Patent application number | Description | Published |
20120246334 | UNIFIED WEB SERVICE URI BUILDER AND VERIFICATION - Verifying a translation middleware piece. A first request is provided to a front end user service using a protocol appropriate for the front end user service, including a translation middleware piece. The translation middleware piece translates requests provided to the front end service to requests for back-end data stores. A first response to the first request to the front end user service is received. A second request is provided to a back-end data store. The second request to the back-end data store is in a format appropriate for the back-end data store and includes elements that should return the same results as the first request to the front end user service. A second response to the second request to the back-end data store is received. Based on the responses, a functional state is determined for at least one of the, front end, the back-end, or the translation middleware piece. | 09-27-2012 |
20130067298 | AUTOMATICALLY ALLOCATING CLIENTS FOR SOFTWARE PROGRAM TESTING - Techniques are described herein that are capable of automatically allocating clients for testing a software program. For instance, a number of the clients that are to be allocated for the testing may be determined based on a workload that is to be imposed by the clients during execution of the testing. For example, the number of the clients may be a minimum number of the clients that is capable of accommodating the workload. In accordance with this example, the minimum number of the clients may be allocated in a targeted environment so that the test may be performed on those clients. Additional clients may be allocated along with the minimum number of the clients in the targeted environment to accommodate excess workload. | 03-14-2013 |
20140317451 | AUTOMATICALLY ALLOCATING CLIENTS FOR SOFTWARE PROGRAM TESTING - Techniques are described herein that are capable of automatically allocating clients for testing a software program. For instance, a number of the clients that are to be allocated for the testing may be determined based on a workload that is to be imposed by the clients during execution of the testing. For example, the number of the clients may be a minimum number of the clients that is capable of accommodating the workload. In accordance with this example, the minimum number of the clients may be allocated in a targeted environment so that the test may be performed on those clients. Additional clients may be allocated along with the minimum number of the clients in the targeted environment to accommodate excess workload. | 10-23-2014 |
Patent application number | Description | Published |
20160006051 | SYSTEM ENERGY DENSITY IN A REDOX FLOW BATTERY - A redox flow battery (RFB) controllable by a battery management system and having an energy output has a volume of at least 2000 liters and an energy density of at least 10 w-h/liter. In one embodiment, the RFB maintains at an energy density of at least 10 w-h/liter for a minimum of 50 continuous full charge/discharge cycles or the equivalent number of operating hours without user input. | 01-07-2016 |
20160006052 | CHARGE CAPACITY MANAGEMENT IN REDOX FLOW BATTERY STRING - A method of operating a redox flow battery string includes providing a plurality of redox flow batteries, each redox flow battery in electrical communication with at least one other redox flow battery, and each redox flow battery comprising an anolyte storage tank including a quantity of anolyte, a catholyte storage tank including a quantity of catholyte, and an electrochemical cell in fluid communication with the anolyte and catholyte storage tanks; obtaining an open circuit voltage value for each redox flow battery in the string; identifying a predetermined open circuit voltage value in the string; and adjusting the open circuit voltage value for each redox flow battery to correspond to the predetermined open circuit voltage value. A redox flow battery string system includes a plurality of redox flow batteries each redox flow battery in electrical communication with at least one other redox flow battery having an open circuit voltage value. | 01-07-2016 |
20160006053 | GAS MANAGEMENT SYSTEMS AND METHODS IN A REDOX FLOW BATTERY - A redox flow battery includes an anolyte storage tank configured for containing a quantity of anolyte and an anolyte headspace; a catholyte storage tank configured for containing a quantity of a catholyte and a catholyte headspace; and a gas management system comprising at least one conduit interconnecting the anolyte headspace and the catholyte headspace, and a gas exchange device configured to contain or release an evolving gas from either or both of the anolyte and catholyte storage tanks to an exterior battery environment when an interior battery pressure exceeds an exterior battery pressure by a predetermined amount. | 01-07-2016 |
20160006054 | SINGLE CAPACITY BALANCING IN A REDOX FLOW BATTERY - A method of operating an all vanadium redox flow battery includes providing an all vanadium redox flow battery comprising an anolyte storage tank including a volume of anolyte and a catholyte storage tank including a volume of catholyte; an electrochemical cell in fluid communication with the anolyte and catholyte storage tanks; and a predetermined range for the ratio of vanadium concentration between the anolyte and the catholyte; and transferring an amount of catholyte from the catholyte storage tank to the anolyte storage tank, or an amount of anolyte from the anolyte storage tank to the catholyte storage tank, to restore the ratio of vanadium concentration to the predetermined range. An all vanadium redox flow battery system includes means for transferring anolyte and catholyte between the anolyte and catholyte storage tanks to maintain a predetermined range for the ratio of vanadium concentration between the anolyte and the catholyte. | 01-07-2016 |
Patent application number | Description | Published |
20120142558 | DIAGNOSTIC LUNG CANCER PANEL AND METHODS FOR ITS USE - Disclosed herein are novel diagnostic lung cancer panels and the use of these panels to diagnose, predict, and characterize lung cancer and to monitor or predict treatment efficacy. | 06-07-2012 |
20120238476 | ALZHEIMER'S DISEASE DIAGNOSTIC PANELS AND METHODS FOR THEIR USE - Novel compositions, methods, assays and kits directed to a diagnostic panel for Alzheimer's disease are provided. In one embodiment, the diagnostic panel includes one or more proteins associated with Alzheimer's disease. | 09-20-2012 |
20130157891 | ORGAN SPECIFIC DIAGNOSTIC PANELS AND METHODS FOR IDENTIFICATION OF ORGAN SPECIFIC PANEL PROTEINS - The present application provides novel compositions, methods, and assays for use in identification of appropriate diagnostic markers in blood. These compositions, methods, and assays are capable of distinguishing normal levels of detectable markers from changes in marker levels that are indicative of changes in health status. | 06-20-2013 |
20130203096 | Selected Reaction Monitoring Assays - Provided herein are methods for developing selected reaction monitoring mass spectrometry (LC-SRM-MS) assays. | 08-08-2013 |
20130217057 | Compositions, Methods and Kits for Diagnosis of Lung Cancer - Methods are provided for identifying biomarker proteins that exhibit differential expression in subjects with a first lung condition versus healthy subjects or subjects with a second lung condition. Also provided are compositions comprising these biomarker proteins and methods of using these biomarker proteins or panels thereof to diagnose, classify, and monitor various lung conditions. The methods and compositions provided herein may be used to diagnose or classify a subject as having lung cancer or a non-cancerous condition, and to distinguish between different types of cancer (e.g., malignant versus benign, SCLC versus NSCLC) | 08-22-2013 |
20130230877 | Compositions, Methods and Kits for Diagnosis of Lung Cancer - Methods are provided for identifying biomarker proteins that exhibit differential expression in subjects with a first lung condition versus healthy subjects or subjects with a second lung condition. Also provided are compositions comprising these biomarker proteins and methods of using these biomarker proteins or panels thereof to diagnose, classify, and monitor various lung conditions. The methods and compositions provided herein may be used to diagnose or classify a subject as having lung cancer or a non-cancerous condition, and to distinguish between different types of cancer (e.g., malignant versus benign, SCLC versus NSCLC) | 09-05-2013 |
20150031065 | COMPOSITIONS, METHODS AND KITS FOR DIAGNOSIS OF LUNG CANCER - The present invention provides methods for identifying biomarker proteins that exhibit differential expression in subjects with a first lung condition versus healthy subjects or subjects with a second lung condition. The present invention also provides compositions comprising these biomarker proteins and methods of using these biomarker proteins or panels thereof to diagnose, classify, and monitor various lung conditions. The methods and compositions provided herein may be used to diagnose or classify a subject as having lung cancer or a non-cancerous condition, and to distinguish between different types of cancer (e.g., malignant versus benign, SCLC versus NSCLC). | 01-29-2015 |
20150087728 | COMPOSITIONS, METHODS AND KITS FOR DIAGNOSIS OF LUNG CANCER - Methods are provided for identifying biomarker proteins that exhibit differential expression in subjects with a first lung condition versus healthy subjects or subjects with a second lung condition. Also provided are compositions comprising these biomarker proteins and methods of using these biomarker proteins or panels thereof to diagnose, classify, and monitor various lung conditions. The methods and compositions provided herein may be used to diagnose or classify a subject as having lung cancer or a non-cancerous condition, and to distinguish between different types of cancer (e.g., malignant versus benign, SCLC versus NSCLC). | 03-26-2015 |
20150198618 | ALZHEIMER'S DISEASE DIAGNOSTIC PANELS AND METHODS FOR THEIR USE - Novel compositions, methods, assays and kits directed to a diagnostic panel for Alzheimer's disease are provided. In one embodiment, the diagnostic panel includes one or more proteins associated with Alzheimer's disease. | 07-16-2015 |
20150219666 | INTEGRATED QUANTIFICATION METHOD FOR PROTEIN MEASUREMENTS IN CLINICAL PROTEOMICS - Methods are provided for determining the expression level of target proteins in a subject. A plurality of respective peptide transitions are generated from a plurality of proteins obtained from a biological sample from the subject, wherein the plurality of proteins comprises both target and normalizing proteins. A mass spectroscopy (MS) signal intensity is measured from the plurality of respective peptide transitions and a plurality of corresponding stable isotope-labeled internal standard (SIS) peptide transitions. For each of the plurality of proteins, a response ratio is calculated between the MS signal intensity of the respective peptide transition and the corresponding SIS peptide transition. The response ratio for each target protein is normalized by a sample-dependent normalization factor calculated from the response ratio for each normalizing protein, wherein the normalized response ratios provide a determination of the expression level of the target proteins. | 08-06-2015 |
20150323545 | SELECTED REACTION MONITORING ASSAYS - Provided herein are methods for developing selected reaction monitoring mass spectrometry (LC-SRM-MS) assays. | 11-12-2015 |